Tag | Content |
---|
EnhancerAtlas ID | HS105-52664 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr22:27159280-27160260 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxd3 | MA0041.1 | chr22:27160063-27160075 | GTTTGTTTGTTT | + | 6.32 | KLF4 | MA0039.3 | chr22:27159820-27159831 | GCAGGGTGTGG | - | 6.62 | MYCN | MA0104.4 | chr22:27160177-27160189 | GGCCACGTGGCC | + | 7.22 | MYCN | MA0104.4 | chr22:27160177-27160189 | GGCCACGTGGCC | - | 7.22 | SOX10 | MA0442.2 | chr22:27159289-27159300 | AAAACAAAGAC | + | 6.14 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH22I026764 | chr22 | 27159661 | 27159850 | GH22I026763 | chr22 | 27159905 | 27160573 |
|
Enhancer Sequence | TTGTCTGCCA AAACAAAGAC CCACGGACTG GGCGGCTTAT ACATGGAAAT GTGTTCTTTC 60 TCTGTTCTGG AGGTTGAAGT CTGAAGCCCA GGTGTTGGCA CCTCGGGCAG CCTCAGGGAT 120 TCGTGGGTTT GTAGACGGCC TTATTCCCAG CTTTCTCCCC ACGTTTTCAC ACTGTTTTCC 180 CTCTATGGTG ATCTGTGTCC AAATCTCCCT TTTGAATAAG GGCACAGTCA TTTTGGAGAA 240 GGGCCTACCC TAACTAACAA CCTCATCTGA ACTCCATCAT CTGCAAAGAC TATTTCCAAA 300 CAAGGTCCCG TTCACAGTTC CTGGGGATTA GGACTTTAAC ATTGTTTTGG GTGACACAAC 360 CTAACCCATG ATAGGCCCAT AATGAAATAA ACATGATACA GTGGTTTCTG AGCATCAGTT 420 GTATACCTGG CATGGTGCCA GGCCCTGGGC ATTCCAAGAT GCTGAGGCGA CATTCCTGCC 480 CTCATGGTGC CCTGAGCACA TTGAAGGAGA CGAATCATTG CTGGGGGAGA GGACCACAGC 540 GCAGGGTGTG GACTGAGGGT GGCGGCACGT GAGCTACATC TCTGGCTTGC AGGAGGCACA 600 TGGGGATGCT CCTTTGCTAT GTTTCTGGCT TGCAAGGGGC ACCCCGGGAT GTTCCTAGAA 660 AGGAAGGTGG CATGATGGTG ACAGCCTTGA TGCCAGGAGA GGAGCTAGCA ACTGAACCAC 720 AGAGACATTC CCAGCAGTCA ACAGGAGCCA CAGATTGATG AGCTAAAGAG TTGTGCAAAC 780 AGTGTTTGTT TGTTTTGTTT GGAGAGGGAA GTCCGTGTGT TTAGAGCTCA GCTTGTCTCC 840 CTCCCTCATG TTACAGGGGA AGAATCGGAG GTTCCGAGTG GGGAGTGACT CTCGCAAGGC 900 CACGTGGCCA GCCACGGCCA AGAGCGACAC CAGAAGGTGA TAGTTCTACT TGCTTCTGAG 960 TCCTTAGAGC GCATAGCCTA 980
|